CLASS II Device recall · Reported 6 Nov 2019 · FDA Enforcement Report

BD Vacutainer Eclipse Blood Collection Needles 22Gx1.25 recalled

Becton Dickinson & is recalling BD Vacutainer Eclipse Blood Collection Needles 22Gx1.25, distributed in 13 states. The recall was initiated on 7 Mar 2019 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot 8207894 ***UPDATED 7/11/19*** Lots 9025826 and 8354527 ***UPDATED 12/10/19*** Lot 9010765
Quantity recalled2,624,160 (2,169,703 US; 454,457 OUS)

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0252-2020
FDA event ID
82351
Recalling firm
Becton Dickinson &, Franklin Lakes, NJ
Classification
Class II
Status
Terminated
Recall initiated
7 Mar 2019
FDA classified
31 Oct 2019
Reported
6 Nov 2019
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Packaging Defects

Timeline

7 Mar 2019Recall initiated by company
31 Oct 2019Classified by FDA+238 days
6 Nov 2019Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

BD PAS received customer complaints indicating the absence of the bevel on the non-patient needle end of the product, causing blood leakage.

Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.

Product as listed by the FDA

BD Vacutainer Eclipse Blood Collection Needles 22Gx1.25, cat. no. 368608

Where it was distributed

Distributed to accounts in AR, CT, FL, IL, IN, MI, MO, MS, NY, OH, TN, TX, and VA. Foreign distribution to Canada, Brazil, India, Mexico, Singapore, and Taiwan.

ArkansasConnecticutFloridaIllinoisIndianaMichiganMissouriMississippiNew YorkOhioTennesseeTexasVirginia

Questions about this recall

Is BD Vacutainer Eclipse Blood Collection Needles 22Gx1.25 recalled?

Yes. Becton Dickinson & recalled BD Vacutainer Eclipse Blood Collection Needles 22Gx1.25 on 7 Mar 2019. The recall is Class II and its status is Terminated. Recall number Z-0252-2020.

Why was it recalled?

BD PAS received customer complaints indicating the absence of the bevel on the non-patient needle end of the product, causing blood leakage.

Which lots are affected?

Lot 8207894 ***UPDATED 7/11/19*** Lots 9025826 and 8354527 ***UPDATED 12/10/19*** Lot 9010765

Where was it sold?

Distributed to accounts in AR, CT, FL, IL, IN, MI, MO, MS, NY, OH, TN, TX, and VA. Foreign distribution to Canada, Brazil, India, Mexico, Singapore, and Taiwan.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Becton Dickinson &

All 361

Other Syringes & Needles recalls

All 1,060